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In vitro fertilization has been available for over 3 decades. Its use is becoming more widespread worldwide, and in
the developed world, up to 5% of children have been born following IVF. It is estimated that over 5 million children
have been conceived in vitro. In addition to giving hope to infertile couples to have their own family, in vitro
fertilization has also introduced risks as well. The risk of multiple gestation and the associated maternal and
neonatal morbidity/mortality has increased significantly over the past few decades. While stricter transfer policies
have eliminated the majority of the high-order multiples, these changes have not yet had much of an impact on
the incidence of twins. A twin pregnancy can be avoided by the transfer of a single embryo only. However, the
traditionally used method of morphologic embryo selection is not predictive enough to allow routine single
embryo transfer; therefore, new screening tools are needed. Time-lapse embryo monitoring allows continuous,
non-invasive embryo observation without the need to remove the embryo from optimal culturing conditions. The
extra information on the cleavage pattern, morphologic changes and embryo development dynamics could help
us identify embryos with a higher implantation potential. These technologic improvements enable us to objectively
select the embryo(s) for transfer based on certain algorithms. In the past 5-6 years, numerous studies have been
published that confirmed the safety of time-lapse technology. In addition, various markers have already been
identified that are associated with the minimal likelihood of implantation and others that are predictive of blastocyst
development, implantation potential, genetic health and pregnancy. Various groups have proposed different
algorithms for embryo selection based on mostly retrospective data analysis. However, large prospective trials are
needed to study the full benefit of these (and potentially new) algorithms before their introduction into daily
practice can be recommended.
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In vitro fertilization (IVF) is one of the fastest developing
fields of medicine. The first birth following successful
treatment was reported in 1978 [1]. According to a 2014
report, in 2005, over 1 million treatment cycles had been
performed worldwide, and in just that year, more than
250,000 children born were conceived in vitro [2]. As of
now, it has been estimated that over 5 million children
have been born as a result of IVF.
Despite the technical developments of the last decades,
there are still problems associated with the treatments
that need to be solved. While many aspects of in vitro
fertilization have improved significantly, the still relativelyCorrespondence: peterkovacs1970@hotmail.com
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unless otherwise stated.low implantation rate often results in the transfer of sev-
eral embryos and leads to multiple gestations.
In 2009, over 400,000 fresh IVF, intracytoplasmic sperm
injection (ICSI) cycles were performed in Europe. One out
of every fifth treatment resulted in a live birth. To achieve
this birth rate, more than 1 embryo was transferred in
over 75% of the cycles. Twenty percent of the deliveries
involved multifetal pregnancies [3]. In 2012, close to
100,000 fresh IVF/ICSI cycles were performed in the
US. The average number of embryos transferred (de-
pending on the age of the patient) was between 1.9 and
2.9. The implantation rate was 37.5% in the youngest
(<35) age group. In this same age group, a 40.7% live
birth rate was achieved but almost 30% of the deliveries
were twin deliveries [4].is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to carry extra maternal and neonatal risks [5] Table 1.
To address the problem of multiple gestations follow-
ing IVF, more restrictive transfer policies have been rec-
ommended and various methods have been studied that
could help embryo selection [6,7].
Single embryo transfer could essentially eliminate mul-
tiple pregnancies. It has been shown that the transfer of
a single embryo reduces the multiple pregnancy rate by
over 90%, but the pregnancy rate is reduced by close to
50% as well [8,9]. However, when a failed single fresh
transfer is followed by the transfer of a single frozen-
thawed embryo, the outcome is similar to that follow-
ing a double fresh embryo transfer (single fresh + single
frozen ET: 38% vs. double ET: 42%; OR: 0.85; 95% CI:
0.62-1.15) [8].
The ability of various screening technologies (preim-
plantation genetic screening, metabolomics, proteomics)
to identify embryo(s) with the highest implantation po-
tential has been evaluated in recent years. Some of these
methods require the use of complicated technology, ne-
cessitate elective embryo cryopreservation and are asso-
ciated with significant treatment expenses. In addition,
most randomized trials do not support their use [10-13].
Preimplantation genetic screening using array comparative
genomic hybridization has been shown to improve clinical
outcome in young, high responder patients [14,15]. Time-
lapse monitoring is another tool that has been evaluated as




Usually the embryologists remove embryos from the in-
cubator once per day to assess cleavage and morphology,
but this type of monitoring only gives them a snapshot
of a dynamic process. The embryos do not tolerate re-
moval from optimal culturing conditions, which limits the
number of observations that can be made. This problem
is a significant one for the embryologists, and time-lapseTable 1 Maternal and perinatal risks associated with
preterm deliveries
Multiple pregnancy





hemorrhage, operative delivery, etc.
Preterm delivery, prematurity,




Increased morbidity, mortality Increased morbidity, mortality,
long-term health consequences
requiring long-term care
Significant increase in health care expensestechnology may offer a solution. With this technology, the
embryos can be monitored without removing them from
the incubator. A camera is built into the incubator and
takes pictures of the embryos at preset intervals. With the
help of the proper software, a video can be made that de-
picts their development. This type of monitoring allows
for the collection of much more information on the tim-
ing of the cleavages and the dynamics of the morphologic
changes. Payne and colleagues [16] were among the first
to describe the early events of human embryonic deve-
lopment, and then, Mio and Meada described the kinetics
of the events up until the blastocyst stage [17]. Their work
was followed by observations made by several other
groups that tried to correlate these kinetic and morpho-
logic markers with embryo development, implantation po-
tential, pregnancy rate and genetic health. This review will
summarize the findings of these publications.
Time-lapse technology
Various time-lapse systems are currently used. Two of
the most widely used technologies, the Primo Vision
(Vitrolife) [18] and Embryoscope (Fertilitech) [19] sys-
tems, both use bright field technology, whereas the
EEVA (Early Embryonic Viability Assessment, Auxogyn)
system uses dark field technology [20]. All systems incorp-
orate a digital inverted microscope that takes a picture of
the embryos at 5-20 minute intervals. The images are
processed by custom image acquisition and then displayed
on a computer screen. The pictures taken at preset inter-
vals are then connected into short films that can be re-
wound and fast forwarded for detailed analysis.
The Embryoscope [19] is an incubator with an inte-
grated time-lapse system, where the embryos, cultured
individually in microwells, are moved one by one into the
field of view of the inbuilt microscope at each of the image
acquisitions. In the Embryoscope system, embryos are cul-
tured in special culture dishes (Embryoslide, Fertilitech).
This multi-well dish allows the monitoring of up to 12 in-
dividually cultured embryos. The Embryoscope can follow
6 of these dishes (max. 72 embryos) simultaneously. It
takes pictures every 12-20 minutes and can evaluate the
embryos in 7 focal planes. It uses low intensity red LED il-
lumination (635 nm) with <0.5 secundum per image light
exposure.
Primo Vision [18] is a compact digital inverted micro-
scope system that is designed to be placed inside of
existing small- to large-sized traditional incubators. Con-
trol of the system, patient database build-up, embryo de-
velopment analysis and decision-making are performed
outside of the incubator through a controlling unit. Em-
bryos in the Primo Vision system are also cultured in
multi-well dishes (Primo Vision embryo culture dish,
Vitrolife) that contain 9-16 wells. However, embryos in
this system are covered by a single drop of culture
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vation while maintaining the benefits of group culture.
The Primo system can monitor up to 16 embryos from
the same patient. The units (maximum of 6) are con-
nected with a controlling unit that is outside the incubator
with a USB connection. The system uses low intensity
green LED (550 nm) illumination and is also able to evalu-
ate the embryos in up to 11 focal planes. Each controlling
unit is able to follow a maximum of 96 embryos at the
same time.
Like the other systems, the EEVA system [20] requires
a special microscope to be placed in the incubator. This
system uses dark field illumination to better outline the
cell membranes. Embryos are cultured in the specially
designed EEVA dish. Based on the timing of the early
cleavage events up until the 4-cell stage, the software se-
lects the embryos that are most likely to develop to the
blastocyst stage. Table 2 summarizes the main character-
istics of the 3 different systems.
The three systems differ in the way that they observe
embryos. In the Embryoscope, the tray holding the cul-
ture dishes is under constant movement to bring each
embryo individually into the field of view. When the tray
is fully loaded (72 embryos), it takes 20 minutes until
the next image of a given embryo is taken. This interval
does not allow the embryologist to detect rapid changes
accurately (e.g., S1 which should last <30-35 min). The
constant movement, electromagnetic effects, heat and
volatile organic compounds released from the lubricants
related to this technology carry the potential to exert ad-
verse effects though no such negative effect has been
directly confirmed yet. However, this technology enables
the system to maximize resolution. Each Primo Vision
microscope is able to monitor up to 16 embryos at the
same time without moving them. With this method, the
embryos are cultured in a completely undisturbed envir-
onment. This system requires significantly less frequent
image acquisitions (because all 16 embryos are observed
at the same time); hence, the exposure to light, electri-
city and electromagnetic effects is even lower than thatTable 2 Comparison of the technical parameters of three com
Embryoscope P
Illumination Bright field, low intensity red LED B




Culture dish Embryoslide 9
c
Embryo culture Single culture G
Planes of view 7 focal planes 1
Max.# of embryos monitored 72 9
Other Comes with software Cpossible with the Embryoscope. This technology, however,
does not provide us with the same image resolution. It
needs to be emphasized that the light exposure compared
to the current standard light microscope evaluation is sig-
nificantly reduced with both systems.
The EEVA system uses dark field illumination, which
allows more accurate observations of the blastomere
membranes; therefore, divisions can be monitored accur-
ately but the method gives far less information regarding
intracellular morphology and has limited ability to follow
embryos beyond day 2 with increasing number of cells.
The automated system could confuse large fragments
with blastomeres, which could therefore affect its se-
lection precision. The dark filed technology, however,
exposes the embryos to significantly higher light load
compared to the other two systems. The EEVA system
comes with software that predicts which embryo is most
likely to turn into a blastocyst based on observations of
early markers by day 2 of development. The use of the
EEVA system has been shown to decrease inter-observer
variability and increase the embryologist’s ability to cor-
rectly identify the best embryos [21].
How does time lapse monitoring help embryo selection?
The current standard in most laboratories is to use mor-
phology for embryo selection. Based on morphologic
characteristics, embryos can be scored at various stages
(pronuclear, cleavage, blastocyst) [22,23]. However, it is
recognized that this approach is far from being perfect
as an average of only approximately 20-40% of the em-
bryos identified this way will implant [3,4].
It has been previously reported, based on the standard
morphologic assessment, that earlier cleaving embryos
have a better chance to develop into blastocysts and im-
plant [24]. It was also noted that embryos that reach the
blastocyst stage are less likely to be aneuploid, and im-
plantation rates are higher when blastocysts are trans-
ferred [25]. Therefore, many centers use extended culture
to the blastocyst stage and perform the transfers on day 5
after retrieval. This practice, however, adds to the work ofmercially available time-lapse systems
rimo vision EEVA
right field, low intensity green LED Dark field
icroscope that can be placed in
tandard incubators
Microscope that can be placed
in standard incubators
-16 well Primo vision embryo
ulture dish
EEVA dish
roup culture Group culture
1 focal planes Single plain
6 Depends on the dish
omes with software Automated, software scores
blastocyst formation potential
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bryology procedures and may be associated with adverse
effects due to epigenetic changes, though the data are
sparse to support such an effect [26,27]. On the other
hand, blastocyst stage transfer has been shown to result in
about a 40% increase in pregnancy rates when compared
to cleavage stage transfer [28]. This improvement may
be due to better embryo selection or improved embryo-
endometrium synchrony. Therefore, despite the slightly
higher cost of the cycle with blastocyst transfer, it may
save money in the long-run by reducing the number of
cycles that have to be performed.
Time-lapse technology is expected to improve the em-
bryologist’s ability to select the embryo with the highest
implantation potential (even by day 3 or at the blastocyst
stage), and this improvement should be translated into
an improved clinical outcome. Automated systems that
identify the embryo(s) to be transferred with the help of
a software program also ease the embryologist’s work.
Before the results of various studies are discussed, the
terminology used by the different papers must be re-
viewed. Unfortunately various papers use different termin-
ology that can be confusing, as discussed by Kirkegaard
and et al. [29]. Mitotic events in the fertilized egg will in-
crease the cell number, and each mitosis will result in the
formation of two cells from the precursor cell. Therefore,
the first mitosis will result in a two-cell embryo, the sec-
ond mitosis in a three-cell embryo and so on. However,
the cell number doubles as the embryo passes through the
cell cycles roughly every 24 hours. The second cell cycle
involves two mitoses: one that will turn a two-cell embryo
into a three-cell embryo and a second one that will turn a
three-cell embryo into a four-cell embryo. On day 4, the
embryo should reach the morula stage and by day 5, the
blastocyst stage. In these stages, the cell number can no
longer be followed, but morphologic changes can be used
to identify them. In papers evaluating time-lapse technol-
ogy, the use “cell cycle” and “cleavage cycle” terminology
is often confusing. A cell cycle will result in two cells while
a cleavage cycle will result in doubling of the cells within
the embryos. Figure 1 summarizes the events up until the
blastocyst stage and explains the various nomenclature,
including a description of certain early events used in the
different publications (Figure 1).
Observations made using time-lapse technology
In a study published in 1997, Payne and colleagues [16]
described their observations based on time-lapse imaging
of 50 fertilized oocytes. Oocytes were randomly selected
for time-lapse imaging, which was initiated 30 minutes
following intracytoplasmic sperm injection (ICSI) fertili-
zation. Three quarters of the oocytes time-lapse observed
fertilized successfully; this rate did not differ from the
sibling oocytes followed under standard conditions. Theproportion of embryos that were considered good quality
embryos on day 3 was also similar between the two me-
thods. Time-lapse observation noted marked variation in
the timings of polar body extrusion, pronuclear formation
and abuttal among the oocytes, and significant differences
were noted between oocytes that formed good versus poor
quality embryos by day 3. In addition, time-lapse technol-
ogy was used to observe several cytoplasmic events, such
as cytoplasmic waves, during the observations made in the
first 24 hours following fertilization.
Lemmen et al. [30] evaluated 102 2PN oocytes using
time-lapse monitoring. Fertilized eggs were randomly as-
signed to time-lapse versus standard observation. By day
2, 58% of the time-lapse observed embryos had deve-
loped to at least the 4-cell stage. A total of 82% of the
fertilized oocytes developed into embryos that were suit-
able for transfer or cryopreservation. This rate was simi-
lar to that obtained in standard incubators. Implanted
embryos had a faster and more synchronous appearance
of the nuclei after the first cleavage. Those embryos that
reached the 4-cell stage by day 2 had a faster disappear-
ance of the pronuclei. Embryos with more cells (≥ 4
cells) on day 2 had a faster first cleavage when compared
to embryos with fewer than 4 cells on day 2. However,
specific time intervals for certain early events to occur
were not provided.
Azzarello and colleagues studied whether pronuclear
stage changes are predictive of live birth. A total of 159
embryos that were transferred on day 2 were analyzed in
a prospective manner, and 46/159 embryos resulted in
live birth. In contrast to the observations made by Lemmen
et al. [30], this group found that pronuclear breakdown oc-
curred significantly later in zygotes that resulted in live
birth when compared to zygotes that failed to result in live
birth. None of the embryos in which the pronuclear break-
down occurred before 20 hours and 45 minutes success-
fully implanted. Several pronuclear scoring systems were
evaluated, but none of them were found to be predictive of
live birth [31].
Wong et al. [32] studied the developmental kinetics of
frozen/thawed fertilized oocytes (n = 242) that had been
donated to research. Various kinetic parameters (for 100
of the 242 embryos) as well as gene expression profiles
(for 142 of 242 embryos) of embryos that reached the
blastocyst stage by day 5 (normal) versus those that did
not reach the blastocyst stage (abnormal) were com-
pared. A total of 33-53% of the 100 embryos cultured to
day 5 or 6 reached the blastocyst stage (a range is given
as there were several experimental sets). Three parameters
were significantly predictive of blastocyst development:
first cytokinesis (mean 14.3 ± 6 min), time between 1st
and 2nd mitosis (mean: 11.1 ± 2.2 hrs), time between 2nd
and 3rd mitosis (mean: 1 ± 1.6 hrs). An automated model
to predict blastocyst formation was developed using these
2 PN oocyte
(Appearance he cleavage furrow) 1st mitosis, interphase 1, CC1
S1
2-cell embryo (t2)








Figure 1 Embryo development from 2PN to blastocyst stage and the various terminology used in the different papers for certain
developmental events.
Kovacs Reproductive Biology and Endocrinology 2014, 12:124 Page 5 of 11
http://www.rbej.com/content/12/1/124
Kovacs Reproductive Biology and Endocrinology 2014, 12:124 Page 6 of 11
http://www.rbej.com/content/12/1/124parameters and was tested on a subset of 14 embryos. All
eight embryos that reached the blastocyst stage were cor-
rectly identified by the model. Abnormal embryos fell out
of the optimal cleavage time ranges or had multiple cleav-
age furrows and displayed significant fragmentation. As
none of the embryos were transferred, these identified
early kinetic markers could not be used to determine im-
proved embryo implantation or pregnancy.
Meseguer et al. [33] studied the kinetics of embryo
development and implantation potential based on the
retrospective analysis of 247 time-lapse embryo obser-
vations in which the implantation for all transferred
embryos was known (0 or 100% implantation). Direct
cleavage from 1→ 3 cells (very short time as a 2-cell
embryo; [< 5 hrs]), uneven blastomeres at the 2-cell
stage (>25% size difference) and multinucleation at the
4-cell stage have been associated with a minimal chance
that these embryos will implant and were suggested as
exclusion criteria by the authors (exclusion from trans-
fer). Furthermore, they divided each kinetic parameter
into time range quartiles. Embryos with cleavage times
(t2,3,4,5) that fell into the 2 middle quartiles (consid-
ered optimal range) were more likely to implant com-
pared to embryos with cleavage times that fell outside
this range. Out of these parameters, cleavage to the 5-
cell stage (t5) within the optimal range was the most
predictive of implantation. When cell cycle parameters
were analyzed, embryos with a CC2 (2→ 3 cell div-
ision) and S2 (3→ 4 cell division) that fell into the first
two quartiles were most likely to implant. Therefore,
these time ranges were determined as optimal. Logistic
regression analysis identified t5 as the most predictive
(followed by S2 and CC2) of implantation. These criteria
were then used to develop a hierarchical model for em-
bryo selection. Embryos with direct cleavage, multinu-
cleation or uneven blastomeres at the 2-cell stage were
excluded (category E). For those embryos not excluded,
t5 was evaluated (optimal range 48.8-56.6 hrs), followed
by S2 (optimal range: ≤ 0.76 hrs) and then CC2 (optimal
range: ≤ 11.9 hrs). Eight categories were created based on
whether the embryo fell into the optimal range or not for
the three parameters. The embryos with the highest
chance to implant fell into the optimal range for all three
parameters.
The significance of the exclusion criteria (direct cleav-
age from 1→ 3 cells) established by Meseguer et al. [33]
were further evaluated by Rubio and colleagues [34].
Embryos were considered to cleave directly when the
2-cell stage was <5 hrs (CC2). The analysis was based
on 1,659 transferred embryos. The overall implantation
rate was 29.2%. A total of 109 of the transferred 1,659
embryos were identified as direct cleaving embryos. Only
1 (1.2%) of the direct cleaving embryos was known to
implant. The implantation rate of the non-direct cleavingembryos (CC2 > 5 hrs) with known implantation was
20.2%.
In a retrospective analysis based of 834 embryos, Cruz
and colleagues [35] assessed whether time-lapse kinetic
parameters can be used to predict blastocyst formation.
For time-lapse categorization, the t5 and S2 time ranges
identified by Meseguer et al. were used, but further kine-
tic markers were compared between embryos that reached
the blastocyst stage versus those that did not. Four cat-
egories were established based on t5 and S2: A: t5 and S2
in the optimal range; B: t5 in the range, while S2 out of
the optimal range; C: t5 out of the optimal range, while S2
in the optimal range; and D: t5 and S2 both out of optimal
range. Embryos with uneven blastomeres at the 2-cell
stage and those directly cleaving from 1→ 3 cells were
less likely to turn into blastocysts or to turn into a blasto-
cyst with good morphology, thereby confirming previous
observations. Cleavage times (t2, t3, t4), CC2, S2 and time
to the morula stage were significantly shorter for those
embryos that had reached the blastocyst stage. T5 how-
ever was similar between those embryos that turned into
blastocysts versus those that did not. When a distinction
was made based on blastocyst morphology, stages t4, t5,
s2 and the time to morula stage were shorter among blas-
tocysts with good morphology when compared to poor
quality blastocysts. The implantation status was known
for 120 embryos (0 or 100%). The implantation rates were
not significantly different among the 4 categories iden-
tified based on t5 and S2 (A: 51.6%, B: 64.2%, C: 34.3%,
D: 30%). This study has shown that kinetic markers are
predictive of blastocyst formation and the development
of blastocysts with good morphology, but the hierarchical
categorization based on t5 and S2 previously proposed by
Meseguer et al. was not able to predict implantation. The
authors offer the relatively small sample size as a possible
explanation for this result.
In a separate retrospective analysis based on 7,305 cy-
cles, the Meseguer lead group [36] compared the preg-
nancy outcome between embryos cultured in standard
incubators (N = 5915) or time-lapse systems (N = 1390).
Embryos cultured in the time-lapse system were scored
according to their previously established hierarchical
model based on t5, S2 and CC2. Data were obtained
from 10 participating clinics. A higher pregnancy rate
(+21.2%) was achieved with the transfer of embryos cul-
tured in the time-lapse system. Logistic regression ana-
lysis was used to correct for confounding variables.
Using the fully corrected model, an increase of 20.1%
based on oocyte retrieval and 15.7% based on embryo
transfer was achieved with embryos cultured in the time-
lapse system. The authors attributed this increase in suc-
cess to the undisturbed culture conditions and the ability
to select embryos for transfer based on strict morphoki-
netic criteria.
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on time-lapse observations made during the assessment of
72 implanted, 106 non-implanted and 66 arrested em-
bryos. Based on the analysis of their time-lapse recordings,
the following kinetic parameters were associated with de-
velopment into viable day 5 embryos: t1 (18.4-30.9 hrs), t2
(21.4-34.8), t4 (33.1-57.2), t8 (46.1-98.5 hrs), and s3 [t8-5]
(0.7-30.8 hrs). None of these parameters, however, were
predictive of successful implantation. The only parameter
that was significantly associated with implantation and
clinical pregnancy was CC3 (9.7-21.0 hrs) [37].
Kinetic parameters up until the 8-cell stage were com-
pared between embryos that had reached and embryos
that had not reached the blastocyst stage in a retrospect-
ive analysis by Dal Canto and colleagues. Furthermore,
kinetic markers between expanded and non-expanded
blastocysts and implanted and non-implanted blastocysts
were compared. Embryos that had turned into blasto-
cysts required a shorter time to reach the 8-cell stage
(61.0 +/- 9.4 hrs vs. 65.2 +/- 13 hrs), but the difference
in timing occurred only after the 6-cell stage. Expanded
blastocysts reached all cellular stages faster and progressed
to the 8-cell stage on average 4 hours sooner than the
non-expanded blastocysts. Finally, implanted blastocysts
required a shorter time to reach the 8-cell stage when
compared to non-implanted blastocysts (54.9 +/- 5.2 hrs
vs. 58.0 +/- 7.2 hrs) [38].
Conaghan and coauthors [21] tested an automated
time-lapse analysis system to determine whether it can
predict blastocyst formation. Their study was a pros-
pective study in which day 3 morphology alone or day 3
morphology supplemented by early embryo viability as-
sessment [EEVA] to predict blastocyst development were
compared. The study involved a development phase in
which the predictive ability of early events (P1: first cyto-
kinesis; P2: time between 1st and 2nd cytokinesis [CC2];
P3: time between 2nd and 3rd cytokinesis [S2]) were
tested. Data from the test phase showed that when P2
(CC2) fell in the 9.33-11.45 hrs range and P3 (S2) fell in
the 0-1.73 hrs range, the probability of developing into a
usable blastocyst was higher (positive predictive value:
54.1%; negative predictive value: 86.6%). In the test phase
it was determined that EEVA assessment significantly im-
proved the predictive value of usable blastocyst identifica-
tion compared to morphology alone (54.7% vs. 34.5%).
Only the predictive ability for blastocyst formation was re-
ported in this study, but implantation and pregnancy rates
were not.
Kirkegaard et al. studied 92 patients with a good prog-
nosis in a prospective cohort study in which they tested
the predictive ability of early time-lapse kinetic parame-
ters (during the first 48 hours of development). The pre-
dictive ability of high-quality blastocyst development
was analyzed based on 571 embryos, whereas pregnancyoutcome was evaluated based on 84 single embryo trans-
fers. The duration of the first cytokinesis, duration of the
3-cell stage and the lack of direct cleavage to 3 cells were
predictive of high-quality blastocyst development. The
kinetic parameters, however, did not significantly differ
between implanted and non-implanted embryos [39].
There have been two randomized controlled trials (RCT)
published so far that evaluated embryo selection for trans-
fer based on time-lapse parameters. The results of the first
trial were published by Kahraman and colleagues [40].
This group randomly assigned the embryos of 64 good
prognosis patients to culturing in a time-lapse system or
under standard incubation conditions. A single blastocyst
was transferred in all cases. The embryo cultured in the
conventional incubator was selected for transfer based on
day 5 morphology. Embryos cultured in the time-lapse
system were selected based on blastocyst morphology and
the hierarchical model suggested by Meseguer et al. (t5,
S2, CC2). The blastocyst development rate was similar for
both incubation methods. Pregnancy (60.6% vs. 61.2% on-
going pregnancy rates) and miscarriage rates were com-
parable as well. Embryo selection based on time-lapse
criteria in addition to morphologic criteria did not further
increase the chance of implantation. While kinetic param-
eters (t 2,3,4,5; time to morula stage; time to blastocyst
stage; CC2, S2) did not differ between embryos that im-
planted (n = 24) and those that failed to implant (n = 9),
blastocysts with good morphology differed significantly
from poor quality blastocysts regarding these parameters.
The second RCT was published recently by Rubio and
colleagues [41]. In this study, 930 good prognosis patients
or patients undergoing egg donation were randomly
assigned to standard incubation and selection based on
morphology alone versus incubation in a time-lapse sys-
tem and embryo selection based on morphokinteic criteria
(Meseguer hierarchical model [33]). The ongoing preg-
nancy rate based on all started cycles was higher in the
time-lapse monitored group (51.4% vs 41.7%; p = 0.005).
When the ongoing pregnancy rate per transfer was evalu-
ated, the time-lapse system still offered benefits over the
standard incubation method (54.5% vs 45.3%; p = 0.01).
This is the only published study so far that was adequately
powered to detect a difference in ongoing pregnancy rates
between standard incubation methods and embryo culture
in a time-lapse system with embryo selection based on
morphokinetic parameters. A logistic regression analysis
controlling for confounding variables found a 36% in-
crease in ongoing pregnancy rates with the time-lapse sys-
tem (OR: 1.36; 95% CI: 1.1-1.68) [41].
Time-lapse parameters and aneuploid
Several groups assessed the association between time-
lapse markers and embryo aneuploidy. Seventy-five fer-
tilized eggs donated to research were analyzed by Chavez
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cleave, and their development was observed using time-
lapse technology for 48 hours. At that stage, all blas-
tomeres of the embryos (185 in total) were tested for
chromosome content using array comparative genomic
hybridization (aCGH). A total of 45 embryos provided
conclusive aCGH data; 17.8% of them were euploid, 75.5%
aneuploid and 6.5% triploid. Euploid embryos followed a
tight pattern regarding early kinetic markers (S1: 14.4+/-
4.2 min, CC2: 11.8+/-0.71 hrs, S2: 0.96+/-0.84 hrs). The de-
velopment of aneuploid embryos was less predictable, the
standard deviation around the mean values was much
greater and many of them had kinetic parameters outside
the optimal range. Chromosomally abnormal embryos
were more likely to display fragmentation.
Basile and colleagues [43] also studied the morphoki-
netic characteristics of chromosomally normal and abnor-
mal embryos. Data were available for 77 embryo transfer
cycles in which day 3 embryo biopsy and aCGH analysis
were performed. A total of 28.3% of the tested embryos
were euploid. Euploid embryos were more likely to fall
into optimal ranges for t5, CC3 and t5-2. Embryos with t5
in the optimal range were 2.8 times more likely, whereas
embryos with CC3 in the optimal range were twice as
likely to be euploid. A total of 36% of those embryos with
both t5-2 and CC3 in the optimal range were euploid,
whereas only 9.8% were euploid when both values were
outside the optimal range.
Campbell and colleagues published two papers [44,45]
about their findings regarding embryo morphokinetic
parameters and genetic health. In their first paper, they
describe their observations made based on 98 blastocysts
from 25 couples. All embryos were followed in time-
lapse systems up until day 5 when trophectoderm biopsy
was performed and either aCGH or single nucleotide po-
lymorphism microarray was applied for genetic screen-
ing. Euploid embryos required a significantly shorter
time to the initiation of compaction, time to the start of
blastulation (tSB) and to full blastulation (tB). Early clea-
vage and cell cycle parameters showed no correlation with
euploidy. A model was developed based on these observa-
tions. According to the model, a low risk for aneuploidy
can be expected when tSB <96.2 hrs and tB <122.9 hrs;
medium risk can be expected when tB <122.9 hrs and
tSB >96.2 hrs and a high risk can be expected when
tB >122.9 hrs [44].
In their second paper, they tested this embryo aneu-
ploidy model. The times to the start of blastulation and
full blastulation were retrospectively applied in cycles
with known implantation. Genetic testing was not per-
formed in these cycles. Overall, 42% of the blastocysts
implanted. Those embryos that were identified to be at
high risk for aneuploidy (tB > 122.9 hrs) did not implant.
In the low risk group (tB < 122.9 hrs and tSB < 96.2 hrs),the live birth rate was 61.1%, which was 56% higher than
the live birth rate in the entire group [44]. The observa-
tions made by Campbell and colleagues were criticized
by Ottolini et al. in their commentary in which they note
that the conclusions were drawn based on small number
of cases without taking age as a confounding factor into
account [46].
Safety
It is important to establish the safety of any new technol-
ogy. The periodic light exposure, electromagnetic effects,
fumes from lubricants and heat accumulation from the
moving parts of the equipment are a potential cause for
concern. There are significant differences regarding light
exposure, potential harm from moving parts and elec-
tromagnetic effects between the different systems. In the
Primo Vision system, embryos are exposed to less light
compared to the Embryoscope, and because there are no
moving parts in the Primo Vision system, one does not
have to worry about potential negative effects related to
this issue. The light exposure of all systems avoids the use
of short wavelength that is potentially detrimental to em-
bryo development. In addition, the overall light exposure
(in all available systems) is much lower than with standard
observation when embryos have to be removed from the
incubators and are exposed to light in the laboratory [33].
Several groups compared fertilization, embryo develop-
ment, blastocyst formation and the implantation potential
of embryos cultured in time-lapse versus standard incuba-
tion systems. Kirkegaard and colleagues [47] randomly
assigned fertilized oocytes (676 oocytes from 59 patients)
to time-lapse incubation/monitoring versus standard mo-
nitoring. Embryos were transferred on day 5. Selection for
transfer was based on blastocyst morphology. Embryos in
both groups were morphologically analyzed on days 2, 3
and 5 by removing them from the culture conditions.
There was no difference in the cleavage rate and blastocyst
formation rate between the two groups. Implantation and
pregnancy rates did not differ either based on 19 and 18
transfers, respectively, in the two groups. The authors
concluded that time-lapse incubation/ monitoring had no
detrimental effects on embryo development.
To date, no negative impact regarding any of these pa-
rameters has been reported [17,29,36,48]. The birth of
the first healthy full term offspring following time-lapse
incubation and selection based on time-lapse parameters
was reported in 2010 [49], but more obstetric, neonatal
and postnatal data are needed to establish to safety of
the technology.
Limitations of time lapse technology
The concept of continuous embryo observation impro-
ving IVF outcome seems sound at first look. The tech-
nology has been shown to exert no harmful effects on
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scientifically before routine clinical application can be
recommended. The primary question is: are more obser-
vations better than a single daily observation for embryo
selection?
This review has detailed several papers that have as-
sessed the clinical utility of time-lapse monitoring. The
reviewed studies already show promising results but suf-
fer from methodological issues. First, essentially all of
the cited studies have a retrospective design. Retrospect-
ive study design cannot account for differences in the
patient populations or culturing conditions. It is well-
known that patients with similar characteristics could
have a different treatment outcome in different clinics.
This fact has been shown in the study by Meseguer et al.
[35] in which the impact of time-lapse monitoring on
clinical pregnancy rate ranged between a few percent de-
crease to a 50% increase among the clinics participating
in a multi-center trial. It is not known how much of this
difference can be attributed to patient characteristics
and how much to the different culture conditions. Cul-
ture conditions in a given lab (e.g., oxygen tension, cul-
ture medium used) could affect embryo development
[50,51]. The genetic integrity of the embryo is, however,
expected to have an even more profound effect on the
early development of the embryo. During embryo cul-
ture, the most crucial task is to differentiate embryos
that will implant from those that will not. We can re-
phrase this statement and say that we need to differenti-
ate the healthy, euploid embryos from the unhealthy,
aneuploid embryos. Time-lapse technology has already
shown us that euploid embryos follow a much tighter
division pattern and aneuploid embryos tend to fall out
of range [42]. Therefore, each lab should test whether
the proposed kinetic parameters are appropriate for their
lab or whether they need to modify them based on their
own results rather than adopting them automatically.
It is also well-known that the treatment outcome de-
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S1: duration of first cytokinesis; CC2: t3-2;S2: t4-3;t5: time to 5-cell stage; CC3: t5-3; tBC:The different studies used different stage (day 2 to blasto-
cyst stage) transfers [31,36,37], which may interfere with
their conclusions regarding the kinetic markers due to
their impact on implantation and pregnancy rates.
The currently proposed time-lapse parameters are not
ready for routine clinical application yet because most of
the published studies have not used clinically meaningful
outcome parameters. Blastocyst formation and implant-
ation rate are important surrogate markers of treatment
efficacy, but neither can be used to replace the live birth
rate or at least the ongoing pregnancy rate. Furthermore,
in some of the discussed studies that are considered
landmark studies [32,42] in the field of time-lapse tech-
nology, embryos have not been transferred and therefore
clinical data are not available. Another problem with the
cited studies is that most of them draw conclusions based
on small number of patients involved, as noted in a com-
mentary by Ottolini et al. [46]. Data on the associations
between ongoing pregnancy rate and live birth rate are
limited at this stage. The above discussed studies involve
mostly retrospective data analysis, and the time ranges for
certain kinetic markers as well as the hierarchical models
have not been properly tested prospectively.
Up until now, two RCTs have been published that com-
pared standard incubation and embryo selection based on
morphology with time-lapse incubation and morphoki-
netic embryo selection. Both trials included good progno-
sis patients or egg donation cycles. The larger study by
Rubio et al. [41], reported an increase in the ongoing preg-
nancy rate among those couples who had their embryos
cultured in the time-lapse system. In addition to the
method of embryo selection (morphology alone vs mor-
phokinetic markers based on various time-lapse parame-
ters) there were significant differences in the culture
conditions as well and this could have affected the results
too. The proportion of good quality day 3 and day 5 em-
bryos was significantly higher in the time-lapse system
and this suggests more optimal incubation conditions.
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<122.9 h (and <96.2 h
time to start of blastulation)
time to blastocyst development.
Kovacs Reproductive Biology and Endocrinology 2014, 12:124 Page 10 of 11
http://www.rbej.com/content/12/1/124of morphokinetic selection in improving outcome cannot
be determined. Both studies included good-prognosis pa-
tients only. Therefore, we can apply these results primarily
in good prognosis patients. If the morphokinetic parame-
ters are predictive of embryo health (and therefore im-
plantation potential) then we should expect the models to
work in a different subset of patients as well. In older pa-
tients or poor responders however, the proportion of em-
bryos that are identified as having a higher implantation
potential is expected to be lower though.
There are further ongoing trials that prospectively
evaluate the benefits of time-lapse technology and their
results should become available before a wider introduc-
tion into clinical care can be made [52].
Conclusions
Time-lapse embryo observation allows us to monitor the
dynamic events of embryo development as they happen
rather than just evaluate snapshots of it. A lot has
already been learned of the events of early embryonic
development, and it has also been shown that if ob-
servations are made only once a day, some of the im-
portant changes the embryo undergoes (e.g., changes in
fragmentation pattern) will be missed, which may result
in the false identification of the best embryo for trans-
fer [42,53,54].
While its full impact on clinical care needs to be ex-
plored, the technology could be useful for research and
industry purposes as the steps of embryo development
can be precisely standardized. Furthermore time-lapse
technology could revolutionize quality control in the lab.
There is also a long way to go before the method’s
routine application for embryo selection can be recom-
mended. Certain parameters have already been iden-
tified that are associated with very low implantation
potential. There are other markers that can predict blas-
tocyst formation and implantation potential, though dif-
ferent groups have identified different markers. There is
little data about the predictive ability of these parame-
ters for clinical pregnancy and live birth (Table 3). A
few hierarchical models (again based on different markers)
have been proposed and tested in retrospective analyses
[21,32,33]. The predictive ability of these markers has to
be tested prospectively and using clinically meaningful
endpoints.
Thus far, the time-lapse technology has proven to be
safe. However, pregnancy and neonatal outcome data
must be collected as well.
Time-lapse technology is just one of the methods that
is currently being evaluated for embryo selection. None
of these technologies are perfect, and rather than look-
ing at them as competing technologies, we should evalu-
ate how they could complete each other and further
improve embryo selection during IVF.In summary, time-lapse technology provides us with a
safe, undisturbed, continuous embryo observation option
that can aid embryo selection and could be used for re-
search purposes. However, the full benefit of the tech-
nology and its place among the other embryo screening
tools remains to be determined.
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